 |
|
|
|
|
|
Medical Affairs Bulletins |
|
|
|
|
|
|
|
|
|
|
|
|
|
| The following literature is available for use by lab and medical professionals.
Just click the thumbnail below to view the full-size image in pdf format. The
pdf version can be saved or printed as needed.
|
Underestimation of LDL-C by Friedewald - Study presented at American College of Cardiology; March 2012
|
JCL – Niacin Simva VAP Study; March 2012
|
The role of Lp(a) - Understanding Lp(a) Cholesterol and Lp(a) Protein Mass; February 2012
|
CIMT Study – Vascular Health and Risk Management; February 2012
|
WellMed Study – Population Health Management; January 2012
|
|
|
"Using the detailed lipid profiles in the VAP Cholesterol Test, we can identify atherosclerosis risk that goes far beyond the capabilities of the standard lipid profile. A cholesterol test which identifies the complete lipid picture can complement lipid risk identification and targeted lipid treatment in our clinical practices."
- Michael E. Cobble, M.D. AAFP, FNLA, Board Certified Clinical Lipidologist (NLA), Certified HTN Specialist (ASH), Masters in Psychopharmacology, Director Private Practice Canyons Medical Center, Adjunct Faculty Univ. Utah School of Medicine |
|
|
The VAP Test
Medical Affairs
